UK markets close in 1 hour 39 minutes

Tibet Pharmaceuticals, Inc. (TBET)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
As of 04:28PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -59.85
52-week change 30.00%
S&P500 52-week change 323.57%
52-week high 30.0001
52-week low 30.0000
50-day moving average 30.0000
200-day moving average 30.0000

Share statistics

Avg vol (3-month) 32k
Avg vol (10-day) 31.31k
Shares outstanding 514.85M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2010
Most-recent quarter (mrq)30 Sept 2011

Profitability

Profit margin 31.79%
Operating margin (ttm)18.81%

Management effectiveness

Return on assets (ttm)17.44%
Return on equity (ttm)32.15%

Income statement

Revenue (ttm)34.05M
Revenue per share (ttm)2.45
Quarterly revenue growth (yoy)-4.90%
Gross profit (ttm)N/A
EBITDA 11.53M
Net income avi to common (ttm)10.82M
Diluted EPS (ttm)0.7790
Quarterly earnings growth (yoy)-57.10%

Balance sheet

Total cash (mrq)25.96M
Total cash per share (mrq)1.75
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)14.48
Book value per share (mrq)3.18

Cash flow statement

Operating cash flow (ttm)6.03M
Levered free cash flow (ttm)1.07M